Deaconess Receives New COVID-19 Treatment for High-Risk Patients
Deaconess says it has received a newly-released COVID-19 treatment that will be used to treat mild-to-moderate cases of COVID-19 in..
WEVV
Indiana to Receive 2,000+ Doses of Eli Lilly COVID-19 Antibody Drug
Credit: WEVV
Duration:
0 shares
1 views
We're learning -- more than 27- hundred doses of eli lilly's antibody drug will be distributed -- across the state.
The hope is to take a bit of the burden*off overwhelmed hospitals.
Taking this drug within the first 10 days of symptoms allowed 70 percent of those people who would have gone to the hospital not to.
The c-e-o emphasizes -- the medicine is only for newly diagnosed patients and it won't help the virus from
You might like
Related news coverage